Clinical Trial Update: Prospective Evaluation of the QoL of Patients With PTS Who Receive Compression Therapy and Sulodexide [Phase 4]

View source ↗

Summary

A Phase 4 study evaluating quality of life in patients with post-thrombotic syndrome receiving compression therapy and sulodexide has been terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Post-thrombotic Syndrome

Drugs mentioned

• Sulodexide (sulodexide)

Snippet

Sponsor: Bama GeVe, S.L.U. | Conditions: Post-thrombotic Syndrome | Phase 4 | Status: TERMINATED